000

BIOTOXTECH CO., LTD.

No trades
See on Supercharts

086040 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. It operates through the following business divisions: Safety Evaluation Research Field, Efficacy Evaluation Research Field, and Analysis Research Field. The Safety Evaluation Research Field division offers studies in areas including general toxicity, local toxicity, reproductive and developmental, genotoxicity, immunotoxicity, carcinogenicity, safety pharmacology, ecotoxicology, histopathology, and hematology. The Efficacy Evaluation Research Field division provides efficacy evaluation and screening materials of medical supplies, health supplements, and cosmetics. The Analysis Research Field division includes the analysis of pharmacokinetics and toxicokinetics, validation, and bioanalysis. The company was founded on August 23, 2000 and is headquartered in Cheongju-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

086040 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company